References
- Steensma, D.P. and Tefferi, A. (2003) "The myelodysplastic syndrome(s): a perspective and review highlighting current contro-versies", Leuk. Res., 27(2), 95–120.
- Clark, D.M. and Lampert, I.A. (1990) "Apoptosis is a common histopathological finding in myelodysplasia: The correlate of ineffective hematopoiesis", Leukemia and Lymphoma, 2, 415–418.
- Raza, A., Gezer, S., Mundle, S., Gao, X.-Z., Alvi, S., Borok, R., etal. (1995) "Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syn-dromes", Blood, 86(1), 268–276.
- Shetty, V., Mundle, S., Alvi, S., Showel, M., Broady-Robinson, L., Dar, S., et al. (1996) "Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes", Leuk. Res., 20(11/12), 891–900.
- Raza, A. (2000) "Anti-TNF therapies in rheumatoid arthritis, Crohn's Disease, sepsis and myelodysplastic syndromes", Microscopy Research and Technique, 50, 229 — 235.
- Raza, A., Meyer, P., Dutt, D., Zorat, F., Lisak, L., Nascimben, F., et al. (2001) "Thalidomide produces transfusion independence in long standing refractory anemias of patients with myelodysplastic syndromes", Blood, 98(4), 958–965.
- Stasi, R. and Amadori, S. (2002) "Infliximab chimeric anti-tumor necrosis factor alpha monoclonal antibody treatment for patients with myelodysplastic syndromes", Br. J. Haematol., 116(2), 334–337.
- Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., et al. (1997) "International scoring system for evaluating prognosis in myelodysplastic syndromes", Blood, 89(6), 2079–2088.
- Cheson, B.D., Bennett, J.M., Kantarjian, H., Pinto, A., Schiffer, C.A., Nimer, S.D., et al. (2000) "Report of an international working group to standardize response criteria for myelodysplastic syn-dromes", Blood, 96(12), 3671–3674.